SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Arcadia Biosciences Q1 EPS $0.290 May Not Compare To $(0.540) Estimate, Sales $309.000K May Not Compare To $800.000K Estimate

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly earnings of $0.290 per share which beat the analyst consensus estimate of $(0.540) by 153.7 percent. This is a 110.98 percent increase over losses of $(2.640) per

Benzinga · 05/13/2020 20:06

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly earnings of $0.290 per share which beat the analyst consensus estimate of $(0.540) by 153.7 percent. This is a 110.98 percent increase over losses of $(2.640) per share from the same period last year. The company reported quarterly sales of $309.000 thousand which missed the analyst consensus estimate of $800.000 thousand by 61.38 percent. This is a 95.57 percent increase over sales of $158.000 thousand the same period last year.